<DOC>
	<DOCNO>NCT01047267</DOCNO>
	<brief_summary>The objective study determine whether pharmacokinetic parameter anidulafungin correlate disease severity plasma protein level critically ill patient .</brief_summary>
	<brief_title>Pharmacokinetics Anidulafungin Intensive Care Unit ( ICU )</brief_title>
	<detailed_description>One risk factor mortality patient candidemia inadequate antifungal therapy . The first day intensive care unit ( ICU ) , patient unstable question whether therapeutic level anidulafungin reach standard loading scheme . At moment several clue PK anidulafungin critically ill patient different , overall picture lacking . For investigation correlation pharmacokinetics anidulafungin disease severity full pharmacokinetic profile obtain . Predictive score system use assess disease severity .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>treatment anidulafungin least 18 year age invasive candidiasis admit intensive care unit allergic anidulafungin excipients contraindication state SPC neutropenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>candidiasis</keyword>
	<keyword>invasive fungal disease</keyword>
	<keyword>critically ill</keyword>
	<keyword>anidulafungin</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>